Primary Care Update Brief Summaries for Clinical Practice: Controlling lnfluenza: Update on Antiviral Agents

Anonymous

首页> 外文期刊>Consultant. >Primary Care Update Brief Summaries for Clinical Practice: Controlling lnfluenza: Update on Antiviral Agents

【24h】

Primary Care Update Brief Summaries for Clinical Practice: Controlling lnfluenza: Update on Antiviral Agents

机译：初级保健更新临床实践摘要：控制流感：抗病毒药物更新

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Although annual vaccination remains the most effective method for preventing seasonal influenza virus infection, antiviral medications can also help reduce the incidence of influenza and its complications. The antiviral agents available for use in the United States are oseltamivir, zanamivir, amanta-dine, and rimantadine. Because more than 99% of currently circulating influenza virus strains are sensitive to oseltamivir and zanamivir, these antiviral agents are recommended. Influenza A (H3N2) and 2009 H1N1 viruses are resistant to adamantanes. The Advisory Committee on Immunization Practices has released guidelines for the use of antiviral medications to control influenza. Highlights of these guidelines are presented here.

机译：尽管每年接种疫苗仍然是预防季节性流感病毒感染的最有效方法，但是抗病毒药物也可以帮助减少流感及其并发症的发生率。在美国可使用的抗病毒药是奥司他韦，扎那米韦，金刚烷胺和金刚乙胺。由于目前超过99％的流行性感冒病毒株对奥司他韦和扎那米韦敏感，因此推荐使用这些抗病毒药物。甲型流感（H3N2）和2009 H1N1病毒对金刚烷有抗性。免疫实践咨询委员会已经发布了使用抗病毒药物控制流感的指南。这些准则的重点在此处介绍。

著录项

来源
《Consultant.》 |2011年第12期|共2页
作者
Anonymous;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医药、卫生;
关键词

相似文献

外文文献
中文文献
专利

1. Primary Care Update Brief Summaries for Clinical Practice: Controlling lnfluenza: Update on Antiviral Agents [J] . Anonymous Consultant. . 2011,第12期

机译：初级保健更新临床实践摘要：控制流感：抗病毒药物更新
2. Primary Care Update Brief Summaries for Clinical Practice:Asthma Eiucation Is a Joint Effort: Guidelines From the NIH [J] . Anonymous Consultant. . 2011,第9期

机译：初级保健更新临床实践摘要：哮喘的缓解是一项共同努力：NIH的指南
3. American Society of Clinical Oncology executive summary of the clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancer. [J] . Van Poznak CH, Temin S, Yee GC, Journal of Clinical Oncology . 2011,第9期

机译：美国临床肿瘤学会临床实践指南的执行摘要，介绍了骨修饰剂在转移性乳腺癌中的作用。
4. Tamoxifens Impact as a Preventive Agent in Clinical Practice and an Update on the STAR Trial [C] . D. Lawrence Wickerham International Society of Cancer Chemoprevention . 2003

机译：Tamoxifens在临床实践中的预防剂和明星试验的更新
5. Updating systematic reviews: The policies and practices of health care organizations involved in evidence synthesis [D] . Garritty, Chantelle Marie 2009

机译：更新系统评价：参与证据综合的卫生保健组织的政策和实践
6. Clinical practice guidelines for the care and treatment of breast cancer: Mastectomy or lumpectomy? The choice of operation for clinical stages I and II breast cancer (summary of the 2002 update) [O] . Hugh Scarth, Jacques Cantin, Mark Levine 2002

机译：乳腺癌护理和治疗的临床实践指南：乳房切除术还是肿块切除术？临床一期和二期乳腺癌的手术选择（2002年更新摘要）
7. ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices—Summary Article A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines) 11This document was approved by the American College of Cardiology Foundation Board of Trustees in September 2002, the American Heart Association Science Advisory and Coordinating Committee in August 2002, and the North American Society for Pacing and Electrophysiology in August 2002.22The ACC/AHA Task Force on Practice Guidelines makes every effort to avoid any actual or potential conflicts of interest that might arise as a result of an outside relationship or personal interest of a member of the writing panel. Specifically, all members of the writing panel are asked to provide disclosure statements of all such relationships that might be perceived as real or potential conflicts of interest. These statements are reviewed by the parent task force, reported orally to all members of the writing panel at the first meeting, and updated as changes occur. The conflict of interest information for the writing committee members is posted on the ACC, AHA, and NASPE Web sites with the full-length version of the update.33When citing this document, the ACC, the AHA, and NASPE would appreciate the following citation format: Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, Kerber RE, Naccarelli GV, Schoenfeld MH, Silka MJ, Winters SL. ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices—Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). J Am Coll Cardiol2002;40:1703–19.44Copies: This document is available on the World Wide Web sites of the ACC (www.acc.org) and the AHA (www.americanheart.org). A single copy of the complete guidelines is available by calling 800-253-4636 (US only) or writing the American College of Cardiology, Resource Center, 9111 Old Georgetown Road, Bethesda, MD 20814-1699 (ask for No. 71-0237). To obtain a copy of the Summary Article, ask for reprint No. 71-0236. To purchase additional reprints (specify version and reprint number): up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 410-528-4426, fax 410-528-4264, or e-mail kbradle@lww.com.55(J Am Coll Cardiol 2002;40:1703–19.)66©2002 by the American College of Cardiology Foundation and the American Heart Association, Inc. [O] . Gregoratos Gabriel, Abrams Jonathan, Epstein Andrew E, 2002

机译：ACC / AHA / NASPE 2002心脏起搏器和抗心律失常装置植入指南更新-总结文章美国心脏病学会/美国心脏协会实践指南工作组的报告（ACC / AHA / NASPE委员会将更新1998年起搏器指南） 11该文件于2002年9月获得美国心脏病学会基金会董事会的批准，于2002年8月获得美国心脏协会科学咨询和协调委员会的批准，并于2002年8月获得北美起搏和电生理学会的批准。22ACC / AHA工作组《实践指南》将尽一切努力避免由于写作小组成员的外部关系或个人利益而引起的任何实际或潜在的利益冲突。具体来说，要求写作小组的所有成员提供所有可能被视为实际或潜在利益冲突的关系的披露声明。这些声明由上级工作组审核，在第一次会议上口头报告给写作小组的所有成员，并在发生变化时进行更新。撰写委员会成员的利益冲突信息已发布在更新的完整版本的ACC，AHA和NASPE网站上。33当引用本文档时，ACC，AHA和NASPE将不胜感激。格式：Gregoratos G，Abrams J，Epstein AE，Freedman RA，Hayes DL，Hlatky MA，Kerber RE，Naccarelli GV，Schoenfeld MH，Silka MJ，Winters SL。 ACC / AHA / NASPE 2002心脏起搏器和抗心律失常装置植入指南更新-总结文章：美国心脏病学会/美国心脏协会实践指南工作组的报告（ACC / AHA / NASPE委员会更新了1998年起搏器指南）。 J Am Coll Cardiol2002； 40：1703–19.44复制：此文档可在ACC（www.acc.org）和AHA（www.americanheart.org）的万维网站点上找到。您可以致电800-253-4636（仅限美国）或写信给美国心脏病学会资源中心，地址为9111 Old Georgetown Road，Bethesda，MD 20814-1699，获得一份完整的指南（请致电71-0237））。要获得摘要文章的副本，请索要第71-0236号转载。要购买其他重印本（指定版本和重印本号码）：最多999份，请致电800-611-6083（仅限美国）或传真413-665-2671；否则，请重新发送。 1000份或更多，请致电410-528-4426，传真410-528-4264或发送电子邮件至kbradle@lww.com.55（J Am Coll Cardiol 2002； 40：1703–19。）66©2002美国心脏病学基金会基金会和美国心脏协会有限公司

Primary Care Update Brief Summaries for Clinical Practice: Controlling lnfluenza: Update on Antiviral Agents

摘要

著录项

相似文献

相关主题

期刊订阅